App, the gene encoding amyloid precursor protein, is widely recognised for its association with neurodegenerative conditions, particularly Alzheimer's disease, where its cleavage product amyloid beta (Aβ) is a key pathological hallmark. Here, APP is linked to Alzheimer disease.